Atrial fibrillation and silent ischemic strokes

Alferova P.A.; Petrova G.A.; Belysheva E.S.; Giliarov M.Yu.; Novikova N.A.

doi:https://doi.org/

Alferova P.A.

Pervyĭ MGMU im. I.M. Sechenova

Petrova G.A.

Nizhni Novgorod State Medical Academy, Nizhni Novgorod, Russia

Belysheva E.S.

Pervyĭ MGMU im. I.M. Sechenova

Giliarov M.Yu.

I.M. Sechenov First Moscow State Medical University under the Ministry of Health of the Russia, 119991, Moscow, Russia;
N.I. Pirogov Moscow Municipal Hospital №1, Moscow, 119049, Russia

SPIN RSCI: 7713-6726
Scopus AuthorID: 6506741565
ResearcherID: Q-2119-2017
ORCID: 0000-0002-2870-3301

Novikova N.A.

Pervyĭ MGMU im. I.M. Sechenova, klinika kardiologii

Atrial fibrillation and silent ischemic strokes

Authors:

Alferova P.A., Petrova G.A., Belysheva E.S., Giliarov M.Yu., Novikova N.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(5): 49‑52

Read: 1392 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Alferova PA, Petrova GA, Belysheva ES, Giliarov MYu, Novikova NA. Atrial fibrillation and silent ischemic strokes. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(5):49‑52. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

References:

Novikova N.A., Sorokina E.G., Gilyarov M.Yu., Sarkisova N.D. Vliyanie gendernykh faktorov na kharakter antitromboticheskoi terapii u patsientov s fibrillyatsiei predserdii. Vestn aritmol 2009; 58: 21-24.
Glebov M.V. Ishemicheskii insul't, paradoksal'naya tserebral'naya emboliya i otkrytoe oval'noe okno: Avtoref. ... dis. kand. med. nauk. M 2009.
Hughes M., Lip G.Y. Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data. Thromb Haemost 2008; 99: 2: 295-304.
Benjamin E.J., Wolf P.A., D'Agostino R.B. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952.
Lip G.Y. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis. Thromb Haemost 2008; 100: 1: 11-13.
Gilyarov M.Yu., Generozov E.V., Magomadova M.U. i dr. Algoritm podbora dozy varfarina s uchetom nositel'stva polimorfizmov genov tsitokhroma CYP2C9 i sub''edinitsy 1 vitamin K epoksidreduktazy. Vestn aritmol 2011; 63: 28-31.
Apostolakis S., Shantsila E., Lip G.Y., Lane D.A. Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation. Thromb Haemost 2009; 102: 5: 914-915.
Healey J.S. Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation. Thromb Haemost 2009; 102: 5: 912-913.
Hart R.G., Pearce L.A., Aguilar M.I. Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
Sherman D.G., Kim S.G., Boop B.S. et al. Occurrence and Characteristics of Stroke Events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) Study. Arch Intern Med 2005; 165: 10: 1185-1191.
Friberg L., Hammar N., Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010; 31: 8: 967-975.
Lip G.Y., Nieuwlaat R., Pisters R. et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation. Chest 2010; 137: 263-272.
Somerfield J. Not all patients with atrial fibrillation-associated ischemic stroke can be started on anticoagulant therapy. Stroke 2006; 37: 1217-1220.
Pisters R. The likelihood of decreasing strokes in atrial fibrillation patients by strict application of guidelines. Europace 2010; 12: 779-784.
Bogousslavsky J., Cachin C., Regli F. et al. Cardiac sources of embolism and cerebral infarction-clinical consequences and vascular concomitants: the lausanne stroke registry. Neurology 1991; 41: 855-859.
Sposato L.A. Newly diagnosed atrial fibrillation after acute ischemic stroke and transient ischemic attack: importance of immediate and prolonged continuous cardiac monitoring. J Stroke Cerebrovasc Dis 2010: 1-7.
Feigin V.L., Lawes C.M.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003; 2: 43-53.
Marini C., De Santis F., Sacco S. et al. Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke: Results From a Population-Based Study. Stroke 2005, 36: 1115-1119.
Das R.R. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study. Stroke 2008; 39: 2929-2935.